INTRODUCTION
Viomycin and capreomycin are tuberculostatic peptide antibiotics ( Fig. 1 ) produced by Streptomyces vinaceus and S. capreolus, respectively (Caltrider, 1967; Herr et al., 1960) . Viomycin inhibits both the initiation and elongation phases of bacterial protein synthesis (Liou & Tanaka, 1976) and in the latter context appears to be a specific inhibitor of translocation (Modolell & Vazquez, 1977) . Despite the fact that recent structural studies have revealed considerable differences between viomycin and the capreomycins (Nomoto et af., 1979, a conceptual association has long been established between these drugs and they are commonly assumed to act similarly.
Two sets of observations prompted us to examine the organisms which produce viomycin and capreomycin. Firstly, in various mutants of Mycobacterium smegmatis, resistance to both drugs could be determined by some undefined property of the RNA of either ribosomal subunit (Yamada et al., 1978) . Secondly, in this laboratory (Cundliffe, 1978;  Cundliffe & Thompson, 1979) another anti biotic-resistance mechanism involving the state of ribosomal RNA (rRNA) had been elucidated. In this case S. azureus, which produces thiostrepton, defends itself by methylation of a specific ribose residue in 23s rRNA. Accordingly, we wished to determine whether (and, if so, how) S. vinaceus and S. capreolus defend themselves against viomycin and capreomycin.
Here we report that these organisms are indeed resistant to their own toxic products, but in a manner radically different from that observed in ,S. azureus. They do not possess drugresistant ribosomes; rather, they elaborate novel, antibiotic-modifying enzymes which can inactivate viomycin and capreomycin in vitro and thus have the potential to participate in self-defence in vivo.
for 2 min. This treatment was necessary in order to reduce the high 'background' in assays of acetyltransferase activity and probably involved removal of endogenous capreomycin.
Ribosomes and SlOO were used to synthesize polyphenylalanine in response to polyuridylic acid [poly(U)] as described previously except that ribosomes were present at a final concentration of 0 . 4 p~ and incubation was at 30°C. In all experiments, an incorporation of 10000 c.p.m. represented approximately 2.5 residues of [ 14C Jphenylalanine polymerized per ribosome.
Antibiotic-susceptibility tests. Suspensions of spores in 3 ml of growth medium containing 0-5 % (w/v) agar were poured over 9 cm diam. nutrient plates (as above) and allowed to set. Paper discs (Whatman AA, 6 mm diam.) containing various antibiotics were placed on the plates which were incubated for 3 d at 30 "C.
Inactivation of viomycin and capreomycin IA by phosphorylation. Assay mixtures contained, in a final volume of 25 pI RS buffer, 7.5 pI S. coelicolor SlOO or 2 pl S. vinuceus SlOO or 10 pl S. capreolus SlOO (previously treated with activated charcoal as above), 4 or 30 pM-antibiotic, and 2.5 mM-MgATP or p,y-methylene adenosine triphosphate (AMPPCP). The time of incubation at 30 "C was 10 min, except for assays containing S. vinaceus SlOO and capreomycin IA, or S. cupreolus SlOO and viomycin, which were incubated for 60 min.
The reaction was stopped by heating at 100 "C for 5 min, followed by centrifugation at 12000g for 1 min.
Samples were removed and the residual drug activity was estimated following dilution (threefold) with the components required for in vitro protein synthesis. These included ribosomes and SlOO from S. coelicolor. Reactivation of phosphoviomycin by alkuline phosphatase. Viomycin was inactivated by incubation at 30 'C for 3 h in 1OOpI RS buffer containing 50pl S. vinaceus SIOO, 5 m-MgATP and 13 phi-viomycin sulphate. A parallel incubation lacking drug was also carried out. The reaction was stopped by heating at 100 ' C for 5 min, followed by centrifugation at 12000g for 1 min. Two samples were removed from each incubation mixture and diluted 15-fold with RS buffer lacking NH.,CI. To one of each pair of samples, E.
coli alkaline phosphatase [Sigma, 100 units ml-l in 2.5 M-(NH,),SO,] was added to a final concentration of 1 unit mi-l. An equal amount of (NH,),SO, was added to the remaining samples. After 20 h at 30 "C, the antibiotic activity in each sample was estimated following dilution (threefold) with components required for in virro protein synthesis, as above. Incubation was continued for a further 30 min at 30 "C and the hot TCAinsoluble radioactivity in 10 p1 samples was determined. were delivered on to strips (3 x 1 cm) of Whatman P81 phosphocellulose paper. These were washed four times with deionized water to remove unreacted radioactive cofactor and then twice with acetone. Radioactivity retained on the papers (representing modified antibiotic) was estimated by liquid-scintillation spectrometry. Background values obtained from control incubations lacking antibiotic were subtracted.
Purification of [14C]acetyicapreomycins I A and IB. Capreomycins IA and JB were acetylated separately as described above, except that the final volume of the reaction mixture was 1 mi, the specific radioactivity of the [l-14C]acetyl-coenzyme A was 7 mCi mmol-1(260 MBq mmol-l), and the time of incubation was 21 h. The reaction mixtures were then applied to columns containing 1 ml Amberlite CG-50 Type I (NH,+ form) which were washed with 4 mi water to remove unreacted cofactor. Radioactive material eluted from each column with 2 ml 2 M-acetic acid was collected, Iyophilized, taken up in a small volume of water and applied to separate tracks on Whatman 3MM paper. The chromatogram was then developed by descending chromatography with n-butanol/acetic acid/water/pyridine (15: 3: 12: 10, by vol.) for 16 h. After drying, the tracks of the chromatogram were cut into 1 cm strips and the radioactivity in each was determined by liquid-scintillation spectrometry. The R p values of capreomycins TA and IB were 0.10 and 0.12, respectively, and those of the acetylated drugs were 0.16 and 0.39. Appropriate strips from each track were washed twice with toluene and then with acetone before being eluted at 37 "C with 2 % acetic acid. The eluates, purified [14C]acetylcapreomycins TA and IB respectively, were lyophilized and dissolved in small volumes of water.
Materials. Antibiotics were obtained from Sigma. Capreomycins IA and IB were purified by the method of 
RESULTS

Antibiotic-resistance in vivo
In conventional disc-plate assays (Fig. 2) , S. vinaceus was found to be highly resistant (but not entirely so) to viornycin, partially resistant to capreomycin IA and sensitive to capreomycin IS. In contrast, S. capreolus was almost completely resistant to all these drugs. Also included in Fig. 2 are results obtained with S. coelicolor (our standard reference actinomycetel which is sensitive to viomycin and the capreomycins. Antibiotic-resistance in vitro Cell-free extracts (S30), active in the poly(U)directed synthesis of polyphenylalanine, were prepared from S. coelicolor and S. vinaceus. The rate of synthesis in extracts of S.
coelicolor was decreased 50 % by 50 ng viomycin ml-l whereas extracts of S. vinaceus were 200 to 300 times less sensitive to the drug. The crude extracts were then fractionated into ribosomes and postribosomal supernatant (S 100) and reciprocal combinations of these were tested for their sensitivity to viomycin as above (Fig. 3) . The results showed that resistance to viomycin was determined exclusively by the SlOO fraction from S. vinaceus and that the ribosomes of this organism were intrinsically sensitive to the antibiotic. In the light of these results, ribosomes were prepared from S. capreolw and tested (using SlOO from S. coelicolor) for sensitivity of polyphenylalanine synthesis to capreomycins IA and IB (Fig. 4) . Again, Table 1 . Inactivation of viomycin and capreomycin IA Viomycin or capreomycin IA at the concentrations specified were incubated with Sl00 from the organisms listed, with or without Cofactor, and their subsequent inhibitory activity against cell-free polyphenylalanine synthesis was determined as described in Methods (final concentrations of antibiotics were one-third of the initial concentrations). In drug-free controk, synthesis proceeded linearly for at least 30 min at which time an average of 22000 c.p. Tanaka, 1978) , it seemed unlikely that resistance to these drugs would be determined by any of the supernatant factors involved in protein synthesis. Rather, it seemed more probable that the producing organisms might contain enzymes capable of inactivating viomycin and capreomycin.
Inactivation of viomycin and capreomycin IA
The biological activity of viomycin or capreomycin IA (i.e. inhibition of cell-free protein synthesis) could be abolished by incubation with ATP together with SlOO from either S. vinaceus or. S. capreolus (Table 1) . Moreover, in the inactivation of viomycin, ATP could not be repiaced by its non-hydrolysable analogue AMPPCP, nor could S. vinaceus SlOO be replaced by that from S. coelicolor. These results suggested that viomycin and capreomycin I A were being inactivated by phosphorylation, a conclusion substantiated by the further At intervals, 20 pl samples were removed and phosphoviomycin was estimated by the phosphocellulose binding technique as described in Methods. Also, 5 pl samples were diluted 15-fold with 10 mM-imidazole/HCI pH 6-8 at 20 "C, heated at 100 "C for 5 min and assayed for inhibition of polyphenylalanine synthesis using components from S. coeficolor. The residual amounts of active drug in the samples were estimated by comparison with the effects of known amounts of viomycin. 0 , Residual active viomycin; 0, [s2P]phosphate transferred to viomycin. observation that inactivated viomycin was reactivated by incubation with alkaline phosphatase (Table 2 ). Subsequently, phosphotransferase activity was assayed directly using the phosphocellulose binding assay (Ozanne et af., 1969) . Postively charged antibiotics, but not negatively charged radiolabelled' ATP, are adsorbed to phosphocellulose paper. Using [y-S*P]ATP and S. vinaceus S100, it was found that viomycin was radioactively phosphorylated, and, furthermore, there was a reciprocal correlation between the extent of phosphorylation and the residual biological activity (Fig. 5) . It appeared that approximately one molecule of phosphate was transferred per molecule of viomycin inactivated.
Substrate speciJicity of antibiotic-modifying enzymes In addition to viomycin, capreomycins I A and IIA were substrates for the phosphotransferases of S. vinaceus and S. capreolus (Table 3) . In this experiment, complete conversion of the antibiotics to phosphorylated product was not achieved because of the need to use less ATP (employed here in radiolabelled form) and more antibiotic than in the druginactivation experiments described above. Significantly, neither enzyme modified aminoglycosides such as streptomycin, neomycin, kanamycin or gentamicin (results not given) although these latter drugs are subject to inactivation by phosphorylation in other systems (for a review, see Davies & Smith, 1978) . We therefore conclude that the viomycin/capreomycin phosphotransferases of S. vinaceus and S. capreolus are novel, antibiotic-inactivating enzymes.
The results of Table 3 also show that all the capreomycins can be acetylated by extracts of S. capreolus. Moreover, when the acetylated forms of capreomycins IA and IB were purified by paper chromatography (see Methods), they were found to be inactive against protein synthesis in vitro (Fig. 6) . Thus, 'capreomycin acetyltransferase ' activity could contribute to the observed resistance of S. capreolus to both capreomycins IA and IB. In contrast, however, the 'capreomycin phosphotransferase' could only protect against capreomycin IA (and the minor component IIA). Although the IA component can be modified either by phosphorylation or by acetylation, these processes may be mutually exclusive since phosphocapreomycin I A could not be acetylated (results not given).
Sites of phosphorylation of viomjvin and capreomycin IA
Phosphorylated viomycin is restored to antibiotic activity by incubation with alkaline phosphatase (Table 2) . Also (results not given), the phosphate group is removed from [ 32P]phosphoviomycin and, at a lower rate, from [32P]phosphocapreomycin IA, by the same enzyme. Since phosphoamides are not substrates for bacterial alkaline phosphatase (Reid & Wilson, I97 I), these results eliminate the possibility that N-phosphorylation occurred. This conclusion is supported by the observation that radiolabelled phosphate was not released from phosphoviomycin by treatment with 1 M-HCl at 100 "C for 60 min, under which conditions N-phosphorylated compounds would be readily hydrolysed. Evidently, inactivation of these antibiotics involves 0-phosphorylation. Radiolabelled phosphoviomycin and phosphocapreomycin IA were then subjected to partial hydrolysis in 2 M-HCl at 1 10 .'C for 4 h followed by high voltage paper electrophoresis at pH 1.9 (Jones & Rodnight, 1971 ) or paper chromatography in solvent containing butanol/acetic acid/water (50: 11 : 25, by vol.). In all hydrolysates, a substantial proportion of the total radioactivity co-migrated with 0-phospho-L-serine which had been added prior to hydrolysis, while most of the remainder was identified as free phosphate (results not given). We therefore concluded that inactivation of viomycin and capreomycin I A resulted from phosphorylation of serine residues. In the case of capreomycin IA there is no ambiguity, but we cannot specify which of the two serines in viomycin is modified.
Sites of acetylation of capreomycins
The sites of acetylation of the capreomycins have not been unequivocally established. There are four potential sites: the a-amino group of a,/3-diaminopropionic acid, the /3-and e-amino groups of p-lysine, and the guanidinium group. In an attempt to distinguish between these possibilities, we compared the electrophoretic mobilities of acetylcapreomycins I A and IB with those of the unmodified antibiotics at various pH values. The rationale behind these experiments was that acetylation would result in a charge change of --1 at pH values below the pKa of the modified group and would reduce the electrophoretic mobility relative to unmodified drug. As shown in Table 4 , the pK, value of the group acetylated in acetylcapreomycin IA was greater than 11 compared with about 8 for the group modified in acetylcapreomycin IB. Apparently, therefore, different groups were acetylated in the different capreomycins. We conclude that the guanidinium group is the probable site of acetylation in capreomycin IA; however, comparison of the published pK, values for capreomycin (Herr, 1963) with those of viomycin, /3-lysine and cc&diamino- form (presumably acetic acid) which did not bind to phosphocellulose paper at pH 2.5.
[ ~4C]Carboxymethyl~pr~omycins would have yielded radioactive degradation products that bound to phosphocellulose.
DISCUSSION
Antibiotic-producing organisms are frequently resistant to their products in vivo (Okami et al., 1969) but there have been relatively few detailed studies of the biochemical bases of such resistance. This is especially so in the case of those organisms which produce inhibitors of ribosome function, although Streptomyces erythreus and S. azureus possess ribosomes which fail to bind erythromycin and thiostrepton, respectively, and are thereby resistant to their own products (Teraoka & Tanaka, 1974; Cundliffe, 1978) . Otherwise, it is less clear how self-defence is achieved since, in all other cases so far examined, the ribosomes of the producing organisms were shown to be fully sensitive to the antibiotics in question. This latter group includes the producers of streptomycin (Cella & Vining, 1974; Piwowarski & Shaw, 1979) , chlorarnphenicol (Malik & Vining, 1972) , and, as reported here, viomycin and capreomycin.
Several streptomycetes which produce aminoglycoside antibiotics contain aminoglycosideinactivating enzymes similar to those which exist as drug-resistance determinants in clinical isolates (Benveniste & Davies, 1973) . The question of whether any such enzyme plays a biosynthetic or protective role (or both) cannot, however, be resolved in the absence of other information. Relevant factors include the sensitivity of the ribosomes to the drug in question, the permeability properties of the cell membrane, and the possibility of intracellular compartmentalization. The present work shows that streptomycetes producing viomycin and capreomycin possess ribosomes which are entirely sensitive to these antibiotics. From this we infer that viomycin and capreornycin do not exist in these organisms in significant concentrations in the same cellular compartments as the ribosomes. Possibly the drugs are synthesized there as inactive precursors, or alternatively they may be produced in separate compartments. In the event that viomycin and capreomycins IA and IIA are produced intracellularly in phosphorylated form, one might predict the existence of phosphatases capable of restoring antibiotic activity extracellularly. In this context, it is noteworthy that the addition of inorganic phosphate to the culture medium of a viomycin-producing streptomycete severely inhibited antibiotic production with a concomitant repression of alkaline phosphatase activity (Pass & Raczynska-Bojanowska, 1968) . One wonders whether, under these conditions, viomycin accumulated as its phosphorylated derivative.
Under appropriate culture conditions, S. vinaceus and S. capreolus produce high external concentrations of viomycin and capreomycin, respectively, and, given that the ribosomes of these organisms are drug-sensitive, it seems logical to suppose that their cell membranes may be relatively impermeable to the drugs. As to the role of the antibiotic-modifying enzymes, they may be involved in the biosynthesis and/or export of the drugs and, since they require ATP or acetyl-coenzyme A as cofactors, we assume that they are either intracellular enzymes or are associated with the cytoplasmic membrane. These enzymes may additionally serve to protect the organisms from any antibiotic which re-enters the cells. If so, resistance is the result of a balance between uptake and inactivation such that the intracellular concentration of antibiotic remains subinhibitory. In this context, we note that S. vinaceus is considerably more resistant to capreomycin IA than to capreomycin IB (Fig. 2) and that its phosphotransferase can inactivate the former, but not the latter. On the other hand, S. vinaceus is substantially more sensitive to capreomycin IA than to viomycin (Fig. 2) , even though the former antibiotic is a better substrate for the phosphotransferase (Table 3 ). This observation would be accounted for if the cell membranes of S. vinaceus were more permeable to capreomycin IA than to viomycin.
Regarding ' capreomycin acetyltransferase ', it is not clear whether this activity is attributable to a single enzyme. Indeed, our results suggest that the sites of acetylation of capreomycins IA and IB may be different, which raises the possibility that there may be different acetyltransferases specific for different components of the capreomycin complex. However, our tentative identification of the sites of acetylation of these molecules requires confirmation by bulk synthesis and physico-chemical analysis. The minor components, capreomycins IIA and IIB, are also acetylated and we assume that they are thereby inactivated, although we have no information regarding the sites of modification.
Antibiotic-modifying enzymes occur widely in drug-resistant bacteria isolated in clinical situations (Davies & Smith, 1978) and an attractive hypothesis suggests that plasmids encoding these enzymes may have acquired the relevant genes directly or indirectly from antibiotic-producing organisms ( 
